Computed tomography pneumogastrography in determining clinical t-stage and yt-stage of gastric cancer
##article.numberofdownloads## 19
##article.numberofviews## 781
pdf (Русский)

Keywords

gastric cancer
early gastric cancer
computed tomography
CT pneumogastrography
T-stage
yT-stage

How to Cite

Amelina, I., Shevkunov, L., Karachun, A. ., Muravtseva, A. ., Mikhnin, A. ., Bagnenko, S. ., & Artemieva, A. . (2021). Computed tomography pneumogastrography in determining clinical t-stage and yt-stage of gastric cancer. Voprosy Onkologii, 67(5), 675–682. https://doi.org/10.37469/0507-3758-2021-67-5-675-682

Abstract

Оbjective. To assess the sensitivity of CT pneumogastrography in determining the T-stage and yT-stage.

Materials and methods. This is a prospective, single-center study that included 267 patients with a histologically diagnosed stomach cancer who received treatment at the N.N. Petrov National Medical Research Center of Oncology from 2015 to 2018. 162 (60.7%) patients underwent preoperative chemotherapy. All patients underwent surgery: 22 in the volume of proximal subtotal gastrectomy, 95 in the volume of distal subtotal resection, 123 in the volume of gastrectomy, and 27 in the volume of endoscopic dissection. All patients underwent staging computed tomography at the preoperative stage according to a single protocol - CT pneumogastrography on a 64-slice X-ray computed tomography. The sensitivity of the method in assessing the depth of invasion was calculated separately for patients without preoperative chemotherapy (T-stage) and for patients who underwent preoperative chemotherapy (уT-stage) by comparison with pathological data.

Results. The sensitivity indicators of CT pneumogastrography for patients without preoperative chemotherapy were: for T1a – 80.6%, T1b – 72.7%, T2 – 80.0%, T3 – 88.0%, T4a – 83.3%, T4b –100%. The sensitivity indicators of CT pneumogastrography for patients receiving preoperative chemotherapy were: for уT2 – 65.2%, уT3 – 83.5%, уT4a – 83.9%, уT4b – 75.0%. It is difficult to restore locally advanced gastric cancer with a depth of invasion cT2 – cT4b in the category yT0, yT1a, and yT1b after preoperative chemotherapy due to the persisting pathological tissue with impaired differentiation of all layers of the stomach wall, which is pathomorphologically a large fibrous tissue.

Сonclusion. CT-pneumogastrography demonstrates high diagnostic indicators in determining the T-stage and yT-stage of gastric cancer.

 

 

https://doi.org/10.37469/0507-3758-2021-67-5-675-682
##article.numberofdownloads## 19
##article.numberofviews## 781
pdf (Русский)

References

Cancer Facts & Figures 2020. Atlanta: American Cancer Society; 2020. https://doi:www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf (accessed April 30, 2021).

Каприн А.Д., Старинский В.В., Шахзадова А.О. Состояние онкологической помощи населению Россиив 2019 г. М., 2020 [Kaprin AD, Starinskiy VV, Shakhzadova AO. The state of cancer care for the population of Russia in 2019. Moscow, 2020 (In Russ.)].

Клинические рекомендации. Рак желудка. Ассоциация онкологов России // Российское общество клинической онкологии. 2018. https://doi:www.oncology.ru/association/clinical-guidelines/2018/rak_zheludka_pr2018.pdf [Clinical guidelines. Stomach cancer. Association of Oncologists of Russia // Rosiiskoe obshchestvo klinicheskoi onkologii. 2018 (In Russ.)]. https://doi:www.oncology.ru/association/clinical-guidelines/2018/rak_zheludka_pr2018.pdf

Давыдов М.И., Тер-Ованесов М.Д., Абдихакимов А.Н., Марчук В.А. Рак желудка: что определяет стандарты хирургического лечения // Практическая онкология. 2001;3(7):18–24 [Davydov MI, Ter-Ovanesov MD, Abdihakimov AN, Marchuk VA. Stomach cancer: which defines the standards of surgical treatment // Prakticheskaya onkologiya. 2001;3(7):18-24 (In Russ.)].

Бесова Н.С., Бяхов М.Ю., Константинова М.М. и др. Практические рекомендации по лекарственному лечению рака желудка // Злокачественные опухоли. 2017;7(3s2):248–260. https://doi:10.18027/2224-5057-2017-7-3s2-248-260 [Besova NS, Byakhov MYu., Konstantinova MM et al. Practical recommendations for drug treatment of stomach cancer // Zlokachestvennye opukholi. 2017;7(3s2):248-26 (In Russ.)]. https://doi:10.18027/2224-5057-2017-7-3s2-248-260

Kim JP, Lee JH, Kim SJ et al. Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer // Gastric cancer. 1998;1(2):125–133. https://doi:10.1007/s101200050006

Болотина Л.В., Крамская Л.В., Дешкина Т.И. и др. Современные подходы к лечению местно-распространенного и резектабельного рака желудка // Онкология. Журнал им. П.А. Герцена. 2015;4(4):52–56. https://doi:10.17116/onkolog20154452-56 [Bolotina LV, Kramskaya LV, Deshkina TI et al. Modern approaches to the treatment of locally advanced and resectable gastric cancer // Oncologiya. im. PA. Hertsena. 2015;4(4):52–56 (In Russ.)]. https://doi:10.17116/onkolog20154452-56

Барышев А.Г., Порханов В.А., Попов А.Ю. и др. Причины рецидива рака желудка у больных после радикального лечения // Сибирский онкологический журнал. 2017;16(1):23–31. https://doi:10.21294/1814-4861-2017-16-1-23-31 [Baryshev AG, Porkhanov VA, Popov AY et al. Reasons for relapse of stomach cancer in patients after radical treatment // Sibirskii onkologicheskii zhurnal. 2017;16 (1):23–31 (In Russ.)]. https://doi:10.21294/1814-4861-2017-16-1-23-31

Давыдов М.И., Тер-Ованесов М.Д., Абдихакимов А.Н., Марчук В.А. Рак желудка: предоперационное обследование и актуальные аспекты стадирования // Практическая онкология. 2001;3(7):9–17 [Davydov MI, Ter-Ovanesov MD, Abdihakimov AN, Marchuk VA. Stomach cancer: preoperative examination and relevant aspects of staging // Prakticheskaya onkologiya. 2001;3(7):9–17 (In Russ.)].

Солодкий В.А., Нуднов Н.В., Чхиквадзе В.Д. и др. Лучевые методы в диагностике и стадировании рака желудка // Медицинская визуализация. 2017;21(6):30–40. https://doi:10.24835/1607-0763-2017-6-30-40 [Solodkiy VA, Nudnov NV, Chkhikvadze VD et al. Radiation methods in the diagnosis and staging of stomach cancer // Meditsinskaya visualizatsiya. 2017;21(6):30–40 (In Russ.)]. https://doi:10.24835/1607-0763-2017-6-30-40

Ставицкая Н.П., Шехтер А.И. Компьютерная томография в диагностике рака желудка (Обзор литературы) // Радиология — Практика. 2008;4:50–59 [Stavitskaya NP, Schechter AI. Computed tomography in the diagnosis of gastric cancer (literature review) // Radiologyiya — Praktika. 2008;4:50–59 (In Russ.)].

Moschetta M, Ianora AAS, Cazzato F et al. The role of computed tomography in the imaging of gastric carcinoma // Management of gastric cancer. 2011. https://doi:10.5772/17437

Патент РФ на изобретение № 2621952. С1 РФ, МПК А61В 6/03 (2006.01), А61К 49/04 (2006.01)/08.06.2017, Бюл. № 16. Амелина И.Д., Мищенко А.В. Способ компьютерно-томографического исследования желудка. https://doi:patents.s3.yandex.net/RU2621952C1_20170608.pdf [Russian Federation patent for invention №. 2621952. C1 RF, IPC A61B 6/03 (2006.01), A61K 49/04 (2006.01)/08.06.2017, Byul. № 16. Amelina I D, Mishchenko AV. Method of computed tomographic examination of the stomach]. https: // patents.s3.yandex.net/RU2621952C1_20170608.pdf

Lee MH, Choi D, Park MJ, Lee MW. Gastric cancer: imaging and staging with MDCT based on the 7th AJCC guidelines // Abdom Imaging. 2012;37(4):531–540. https://doi:10.1007/s00261-011-9780-3

Seevaratnam R, Cardoso R, Mcgregor C et al. How useful is preoperative imaging for tumor, node, metastasis (TNM) staging of gastric cancer? A meta-analysis // Gastric Cancer. 2012;15(1):S3–S18. https://doi:10.1007/s10120-011-0069-6

Kim AY, Kim HJ, Ha HK. Gastric cancer by multidetector row CT: preoperative staging. Department of radiology, Asan medical center, University of Ulsan College of Medicine, 388-1, Poongnap-Dong, Songpa-Ku, Seoul, 138-736, Korea. Abdom Imaging. 2005;30:465–472. https://doi:10.1007/s00261-004-0273-5

Habermann CR, Weiss F, Riecken R et al. Preoperative staging of gastric adenocarcinoma: comparison of helical CT and endoscopic US // Radiology. 2004;230:465–471.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

© АННМО «Вопросы онкологии», Copyright (c) 2021